Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Future molecules in heart failure].

L Hittinger1, M E Lopes, J Y Tabet

  • 1Fédération des services de Cardiologie et service de Médecíne Nucléaire, INSERM U400 et Centre de Recherches Chirurgicales, Hôpital Henri Mondor, Créteil. luc.hittinger@hmn.ap-hop-paris.fr

Presse Medicale (Paris, France : 1983)
|February 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fungal Planet description sheets: 1550-1613.

Persoonia·2024
Same author

Immune response to pertussis vaccine in COPD patients.

Scientific reports·2023
Same author

[The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2022
Same author

[Analysis of perineural invasion with clinicopathological factors and prognosis for curatively resected gallbladder carcinoma].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2022
Same author

[Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2022
Same author

[Prognostic value of preoperative peripheral blood neutrophil-to-lymphocyte ratio and γ-glutamyl transpeptidase-to-platelet ratio index in patients with hepatitis B virus related intrahepatic cholangiocarcinoma after radical resection].

Zhonghua yi xue za zhi·2021
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Heart failure (HF) management is evolving with new strategies targeting neurohormone and immune systems. Personalized treatment plans based on patient profiling will optimize future HF care.

Area of Science:

  • Cardiology
  • Pharmacology
  • Biomedical Science

Context:

  • Heart failure (HF) management has advanced significantly.
  • Current treatments focus on congestion and neurohormone inhibition.
  • New therapeutic avenues are emerging based on novel physiological concepts.

Purpose:

  • To explore future therapeutic strategies for heart failure.
  • To identify principles for optimizing HF treatment personalization.
  • To discuss the role of new diagnostic and therapeutic approaches.

Summary:

  • Future HF management may involve blocking vasoconstrictor systems and stimulating vasodilator/natriuretic systems.
  • Modulating cardiac remodelling, immune/inflammatory responses, contractility, and arrhythmias are potential strategies.

Related Experiment Videos

  • Personalized medicine, using advanced diagnostics and patient stratification, is key to future HF treatment.

    • Impact:

    • Predicting which novel strategies will improve HF prognosis requires further large-scale randomized studies.
    • Optimizing treatment involves measuring hormone levels (e.g., B-type natriuretic peptide) and using advanced imaging.
    • Classifying patients by etiology, disease profile, and genetic factors will enable tailored HF therapies.